FindTrial
Sign In

Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki University

Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki University - Early arthritis cohort against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki University

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014881
Enrollment
250
Registered
2014-09-01
Start date
2015-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early arthritis

Interventions

The information of musculoskeletal ultrasonography is provided to physician. The information of musculoskeletalultrasonography is not provided to physician.

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients provided a signed consent form to participate in the study, which is approved by the each institutional review board 2. Patients with early arthritis disease duration less than 6 months.

Exclusion criteria

Exclusion criteria: 1. Under twenty years old 2. Non-RA rheumatic diseases

Design outcomes

Primary

MeasureTime frame
1. Progression rate of definitive RA from early arthritis after treatment for 12 months 2. SDAI remission rate and no radiographic progression rate 3.HAQ remission rate 4. Musculoskeletal ultrasonography remission rate (Total Power Doppler score <2)—

Countries

Japan

Contacts

Public ContactMami Tamai

Nagasaki University Hospital First department of internal medicine

tamai-ngs@umin.ac.jp095-819-7262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026